ARTICLE | Company News
SKP licenses EU DepoCyte rights to ELN
July 25, 2001 7:00 AM UTC
SkyePharma (LSE:SKP; SKYE) licensed European and Philippine marketing rights for its DepoCyte cytarabine liposome injection for lymphomatous meningitis to Elan (ELN). SKP received a $10 million signin...